Small molecule inhibitors to reprogram the tumour environment and improve immunotherapy

  • Ganss, Ruth (Chief Investigator)
  • Hammerling, Gunter (Chief Investigator)
StatusActive
Effective start/end date1/01/1831/12/20

Funding

  • National Health & Medical Research Council NHMRC